Does induction chemotherapy still have a role in larynx preservation strategies? The experience of institut catala d'oncologia in stage III larynx carcinoma

Laryngoscope

Volumn 116, Issue 9, 2006, Pages 1651-1656

  Majem, Margarita ^a,c   Mesia, Ricard ^a   Mañós, Manel ^a   Gomez, Joaquin ^a   Galiana, Ramon ^a   Cardenal, Felipe ^a   Juan, Amparo ^a   Montes, Ana ^a   Perez, Francisco Javier ^b   Nogues, Julio ^a   Llluch, Josep Ramon Germa ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

Hyperfractionation radiotherapy; Induction chemotherapy; Larynx cancer; Larynx preservation; Total laryngectomy

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADULT; AGED; ANEMIA; ANGINA PECTORIS; ARTICLE; ASPIRATION PNEUMONIA; BRAIN INFARCTION; CANCER STAGING; CANCER SURVIVAL; CARDIOVASCULAR DISEASE; CHRONIC TOXICITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIARRHEA; DYSPHAGIA; FEMALE; FOLLOW UP; FRACTIONATION; GASTROINTESTINAL DISEASE; HEMATOLOGIC DISEASE; HUMAN; HUMAN TISSUE; LARYNGECTOMY; LARYNGOSCOPY; LARYNX CARCINOMA; LARYNX EDEMA; MAJOR CLINICAL STUDY; MALE; NECROSIS; NEUTROPENIA; ORGAN PRESERVATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; STOMATITIS; SURGICAL TECHNIQUE; TRACHEOTOMY; TREATMENT OUTCOME; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; FLUOROURACIL; HUMANS; LARYNGEAL NEOPLASMS; LARYNGECTOMY; LARYNGOSCOPY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; REMISSION INDUCTION; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33748528633     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000231736.08477.47     Document Type: Article

References (15)

1. Ferlito A, Shaha AR, Lefebvre JL, Silver CE, Rinaldo A. Organ and voice preservation in advanced laryngeal cancer. Acta Otolaryngol 2002;122:438-442.
2. Hanna E, Sherman A, Cash D, et al. Quality of life for patients following total laryngectomy vs. chemoradiation for laryngeal preservation. Arch Otolaryngol Head Neck Surg 2004;130:875-879.
3. Fung K, Lyden TH, Lee J, et al. Voice and swallowing outcomes of an organ-preservation trial for advanced laryngeal cancer. Int J Radiat Oncol Biol Phys 2005;63:1395-1399.
4. VA Laryngeal Cancer Study Group. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study Group. N Engl J Med 1991;324:1685-1690.
5. Forastiere AA, Goepfert H, Maor M, et al. Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091-2098.
6. Pinto LH, Canary PC, Araujo CM, Bacelar SC, Souhami L. Prospective randomized trial comparing hyperfractionated versus conventional radiotherapy in stages III and IV oropharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1991;21:557-562.
7. Horiot JC, Le Fur R, N'Guyen T, et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trial of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992;25:231-241.
8. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998;338:1798-1804.
9. Galiana R, Boladeras A, Mesia R, et al. Twice-a-day radiotherapy for head and neck cancer: the Catalan Institute of Oncology experience. Radiother Oncol 2002;64:19-27.
10. Hitt R, Lopez-Pousa A, Martinez-Trufero J, et al. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 2005;23:8636-8645.
11. Vermorken JB, Van Herpen C. EORTC 24971/TAX 323. A randomized phase III multicenter trial of neoadjuvant docetaxel plus cisplatin plus 5-fluorouracil in patients with locally advanced unresectable squamous cell carcinoma of the head and neck. Proc ASCO; 2004.
12. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;35:567-578.
13. de Andres L, Brunet J, Lopez-Pousa A, et al. Function preservation in stage III squamous laryngeal carcinoma: results with an induction chemotherapy protocol. Laryngoscope 1995;105:822-826.
14. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000;48:7-16.
15. Adelstein DJ, Li Y, Adams GL, et al. An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003;21:92-98.